Pharmacokinetics of liposomal busulphan in man

Bone Marrow Transplantation

Volumn 27, Issue 5, 2001, Pages 479-485

  Hassan, Z ^a   Ljungman, P ^a   Ringden O ^a   Winiarski, J ^a   Nilsson, C ^a   Aschan, J ^a   Whitley, H Rosengren ^a   Hassan, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone marrow transplantation; Busulphan; Liposomal busulphan; Man; Pharmacokinetics

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; LIPOSOME;

ADOLESCENT; ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG MONITORING; FEMALE; FLUSHING; HUMAN; LINEAR SYSTEM; MALE; PHARMACOKINETICS; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; AREA UNDER CURVE; BODY WEIGHT; BUSULFAN; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LIPOSOMES; MALE; MIDDLE AGED; TRANSPLANTATION CONDITIONING;

EID: 0035065688     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702823     Document Type: Article

References (33)

1. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: A report from the de Moelle Osseuse
2. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide
3. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first Oncology Group study
4. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group
5. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working European Group for Blood and Marrow Transplantation (EBMT)
6. Busulfan disposition in children
7. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology
8. Busulfan disposition below the age of three: Alteration in children with lysosomal storage disease
9. Busulfan bioavailability
10. Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
11. Dose-dependent neurotoxicity of high-dose busulfan in children: A clinical and pharmacological study
12. Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders
13. An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children
14. Use of a water-soluble busulfan formulation - Pharmacokinetic studies in a canine model
15. Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy
16. Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation
17. Acute and subchronic toxicity of dimethylformamide and dimethylacetamide following various routes of administration
18. Inhalation studies in rats exposed to dimethylacetamide (DMAc) from 3 to 12 hours per day
19. Dimethylsulphoxide-induced toxicity
20. A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation
21. Pharmacokinetics and distribution of liposomal busulfan in the rat: A new formulation for intravenous administration
22. Liposomal busulphan: Bioavailability and effect on bone marrow in mice
23. Use of liposomes as injectable-drug delivery systems
24. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
25. Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation
26. Gas chromatographic determination of busulfan in plasma with electron-capture detection
27. Chronopharmacology of high-dose busulfan in children
28. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients
29. Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan
30. Pharmacokinetics of high-dose busulfan in children
31. Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia
32. Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation